Skip to content

Prospective Randomized Trial On Episiorrhaphy

Prospective Randomized Trial Comparing Outcomes Of Episiorrhaphy Using Vicryl Rapid Coated 2/0 Versus Vicryl 2/0 Plus Triclosan

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07045285
Acronym
VICRYL
Enrollment
100
Registered
2025-07-01
Start date
2025-06-01
Completion date
2025-09-30
Last updated
2025-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suture Materials

Keywords

Episiotomy, pregnancy

Brief summary

An episiotomy refers to the incision of the perineum performed to increase the space of the vaginal opening to facilitate the birth of the newborn. Subsequently, the incision is closed by aligning the tissues without cutaneous and vascular alterations. Although a systematic review and metanalysis demonstrated that sutures coated with triclosan, a purified antimicrobial, prevent surgical site infections, there is no evidence in the literature regarding the use of antibacterial sutures for perineal plane compared to standard ones. Therefore, the goal of this clinical trial is to compare the outcomes of incisions performed with standard Vicryl 2/0 sutures and antibacterial Vicryl Plus 2/0 sutures. The study involves women giving birth at the Vittore Buzzi Children's Hospital, for whom an incision is necessary at the time of delivery. Participants will be evaluated at 48 hours (at the time of the hospital discharge visit), 40 days (at the postpartum visit), and 6 months (by phone interview) after delivery. In particular, the aim of this study is to assess whether: * antibacterial Vicryl Plus 2/0 sutures reduce pain after delivery; * antibacterial Vicryl Plus 2/0 sutures improve the overall wound healing rate, avoid sexual, urinary or bowel disorders and the need for additional pharmacological, surgical, or physiotherapeutic interventions (in case of suboptimal wound healing). This study also aims to validate a new ASEPSIS ( Additional Treatment, Serous exudate, Erythema, Purulent exudate, Separation of deep tissues, Isolation of bacteria and Stay) score for the evaluation of healing outcomes of episiotomies. This is a double-blind, parallel-group randomized controlled trial. After obtaining informed consent, participants are randomly assigned either to the experimental group or the control group. Participants do not know the group they belong to, as the researchers; only the healthcare professional performing the suture knows it.

Interventions

DEVICEAntibacterial Vicryl Plus 2/0

antibacterial Vicryl Plus 2/0 sutures are multifilament absorbable synthetic sutures that are coated with triclosan, a purified antimicrobial.

DEVICEStandard Vicryl 2/0

Vicryl rapid coated 2/0 sutures are multifilament absorbable synthetic sutures not treated with any antimicrobial.

Sponsors

ASST Fatebenefratelli Sacco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* pregnant women at term (more than 37 weeks); * age between 18 and 40 years; * women who give consent to participate in the study; * women who give birth during the recruitment period; * women for whom an episiotomy is necessary at the time of delivery.

Exclusion criteria

* age lower than 18 years and more than 40 years; * gestational age lower than 37 weeks; * diabetes mellitus or gestational diabetes; * African and South-East Asian ethnicities; * cigarette smoking; * BMI higher than 30; * anemia; * lack of consent to participate; * complicated episiotomy and/or presence of other spontaneous perineal lacerations; * women lost to follow-up or who have undergone non-gynecological perineal interventions during the follow-up period.

Design outcomes

Primary

MeasureTime frameDescription
Pain evaluation48 hours, 40 days and six months postpartum.Pain is defined through a Swab test (based on a pain scale known as the Visual Analogue scale (VAS) with a score from 0 to 10 (0= no pain, 10=worst imaginable pain)

Secondary

MeasureTime frameDescription
Re-suturingat 48 hours and 40 days after deliveryRe-suturing (performed or not performed)
Wound Healing Status Assessed by ASEPSIS Score48 hours, 40 days and six months postpartum.The ASEPSIS (Additional treatment, Serous exudate, Erythema, Purulent exudate, Separation of deep tissues, Isolation of bacteria, and Stay) score evaluates the extent of wound healing complications after delivery. It quantifies serous exudate, erythema, purulent exudate, and wound dehiscence on the suture line. Additional points are assigned for antibiotic use, drainage of purulent material, bacterial isolation from cultures, and hospitalization exceeding 14 days. Scores range from 0 to over 40, with higher scores indicating more severe wound infection or healing disturbance.
Functional disorders secondary to episiotomy repairAssessed at 6 months postpartumAssessment of dyspareunia (present or absent), urinary disorders (present or absent) ,and bowel disorders (present or absent)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026